Paragon 28 Inc. is a medical device company exclusively focused on the foot and ankle orthopedic market. Paragon 28 Inc. is based in ENGLEWOOD, Colo.
| Revenue (Most Recent Fiscal Year) | $216.39M |
| Net Income (Most Recent Fiscal Year) | $-57.53M |
| PE Ratio (Current Year Earnings Estimate) | -- |
| PE Ratio (Trailing 12 Months) | -- |
| PEG Ratio (Long Term Growth Estimate) | -- |
| Price to Sales Ratio (Trailing 12 Months) | 4.45 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 7.80 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | -- |
| Pre-Tax Margin (Trailing 12 Months) | -26.58% |
| Net Margin (Trailing 12 Months) | -25.31% |
| Return on Equity (Trailing 12 Months) | -37.90% |
| Return on Assets (Trailing 12 Months) | -18.22% |
| Current Ratio (Most Recent Fiscal Quarter) | 3.50 |
| Quick Ratio (Most Recent Fiscal Quarter) | 1.60 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 0.79 |
| Inventory Turnover (Trailing 12 Months) | 0.67 |
| Book Value per Share (Most Recent Fiscal Quarter) | $2.05 |
| Earnings per Share (Most Recent Fiscal Quarter) | $-0.15 |
| Earnings per Share (Most Recent Fiscal Year) | $-0.53 |
| Diluted Earnings per Share (Trailing 12 Months) | $-0.74 |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Medical Devices |
| Common Shares Outstanding | 83.72M |
| Free Float | 70.89M |
| Market Capitalization | $1.09B |
| Average Volume (Last 20 Days) | 2.30M |
| Beta (Past 60 Months) | 1.54 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 15.32% |
| Percentage Held By Institutions (Latest 13F Reports) | 63.57% |
| Annual Dividend (Based on Last Quarter) | $0.00 |
| Dividend Yield (Based on Last Quarter) | 0.00% |